Welcome to our dedicated page for Innocan Pharma news (Ticker: INNPF), a resource for investors and traders seeking the latest updates and insights on Innocan Pharma stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Innocan Pharma's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Innocan Pharma's position in the market.
Innocan Pharma (CSE: INNO, FSE: IP4, OTCQB: INNPF) has announced its participation in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. This event brings together institutional investors, corporate clients, and industry professionals to showcase innovations and financial strategies.
The company will highlight its recent regulatory achievements, including FDA approval for a 505(2)(b) abbreviated pathway for human health applications, a sponsor fee waiver, and an Investigational New Animal Drug number (INAD) for animal health applications from the FDA Center for Veterinary Medicine.
Iris Bincovich, CEO of Innocan Pharma, will present at 2PM ET in the Lotus Suite West. The management team will also conduct one-on-one investor meetings throughout the day. Interested investors can register to attend and schedule meetings online.
FAQ
What is the current stock price of Innocan Pharma (INNPF)?
What is the market cap of Innocan Pharma (INNPF)?
